Tumor expression of alternatively spliced tissue factor is a prognostic marker in non-small cell lung cancer

Tissue Factor Expression in Non-small Cell Lung Cancer: Relationship with Vascular Endothelial Growth Factor Expression, Microvascular Density, and K-ras Mutation

(2010) Sandra Regina et al.   Journal of Thoracic Oncology

Role of the Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway in Regulating Alternative Splicing of Tissue Factor mRNA in Human Endothelial Cells

(2009) Andreas Eisenreich et al.   CIRCULATION JOURNAL

Increased Tissue Factor Expression Is Associated with Reduced Survival in Non-Small Cell Lung Cancer and with Mutations of TP53 and PTEN

(2009) S. Regina et al.   CLINICAL CHEMISTRY

Role of Tissue Factor in Cancer

(2009) Raj S. Kasthuri et al.   JOURNAL OF CLINICAL ONCOLOGY

Human alternatively spliced tissue factor is not secreted and does not trigger coagulation

(2009) A. N. BÖING et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Alternatively spliced tissue factor induces angiogenesis through integrin ligation

(2009) Y. W. van den Berg et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Tissue factor in cancer

(2008) Janusz Rak et al.   CURRENT OPINION IN HEMATOLOGY

Role of Alternatively Spliced Tissue Factor in Pancreatic Cancer Growth and Angiogenesis

(2008) Maxim Signaevsky et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS